Whole genome sequencing diagnostic yield for paediatric patients with suspected genetic disorders: systematic review, meta-analysis, and GRADE assessment
Open Access
- 25 May 2023
- journal article
- review article
- Published by Springer Nature in Archives of Public Health
- Vol. 81 (1) , 1-12
Abstract
Background: About 80% of the roughly 7,000 known rare diseases are single gene disorders, about 85% of which are ultra-rare, affecting less than one in one million individuals. NGS technologies, in particular whole genome sequencing (WGS) in paediatric patients suffering from severe disorders of likely genetic origin improve the diagnostic yield allowing targeted, effective care and management. The aim of this study is to perform a systematic review and meta-analysis to assess the effectiveness of WGS, with respect to whole exome sequencing (WES) and/or usual care, for the diagnosis of suspected genetic disorders among the paediatric population.Methods: A systematic review of the literature was conducted querying relevant electronic databases, including MEDLINE, EMBASE, ISI Web of Science, and Scopus from January 2010 to June 2022. A random-effect meta-analysis was run to inspect the diagnostic yield of different techniques. A network meta-analysis was also performed to directly assess the comparison between WGS and WES.Results: Of the 4,927 initially retrieved articles, thirty-nine met the inclusion criteria. Overall results highlighted a significantly higher pooled diagnostic yield for WGS, 38.6% (95% CI: [32.6 – 45.0]), in respect to WES, 37.8% (95% CI: [32.9 – 42.9]) and usual care, 7.8% (95% CI: [4.4 – 13.2]). The meta-regression output suggested a higher diagnostic yield of the WGS compared to WES after controlling for the type of disease (monogenic vs non-monogenic), with a tendency to better diagnostic performances for Mendelian diseases. The network meta-analysis showed a higher diagnostic yield for WGS compared to WES (OR = 1.54, 95%CI: [1.11 – 2.12]).Conclusions: Although whole genome sequencing for the paediatric population with suspected genetic disorders provided an accurate and early genetic diagnosis in a high proportion of cases, further research is needed for evaluating costs, effectiveness, and cost-effectiveness of WGS and achieving an informed decision-making process.Trial Registration: This systematic review has not been registered.Keywords
Funding Information
- Ministero della Salute (RF-2018–12,366,391, 2018, RF-2018–12,366,391, 2018, RF-2018–12,366,391, 2018, RF-2018–12,366,391, 2018, RF-2018–12,366,391, 2018, RF-2018–12,366,391, 2018, RF-2018–12,366,391, 2018, RF-2018–12,366,391, 2018, RF-2018–12,366,391, 2018, RF-2018–12,366,391, 2018)
This publication has 73 references indexed in Scilit:
- Selecting the best scale for measuring treatment effect in a network meta‐analysis: a case study in childhood nocturnal enuresisResearch Synthesis Methods, 2012
- QUADAS-2: A Revised Tool for the Quality Assessment of Diagnostic Accuracy StudiesAnnals of Internal Medicine, 2011
- GRADE guidelines: 3. Rating the quality of evidenceJournal of Clinical Epidemiology, 2011
- GRADE guidelines: 1. Introduction—GRADE evidence profiles and summary of findings tablesJournal of Clinical Epidemiology, 2011
- Frequency of Treatment-Effect Modification Affecting Indirect ComparisonsPharmacoEconomics, 2010
- A basic introduction to fixed-effect and random-effects models for meta-analysisResearch Synthesis Methods, 2010
- Indirect comparison: relative risk fallacies and odds solutionJournal of Clinical Epidemiology, 2009
- Defining the Review Question and Developing Criteria for Including Studies2008
- The impact of genetics and genomics on public healthEuropean Journal of Human Genetics, 2007
- Measuring inconsistency in meta-analysesBMJ, 2003